Researchers analyzed associations between the severity and etiology of bronchiolitis in the first 2 years of life and subsequent pediatric asthma/recurrent wheezing.
Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report.
Increases seen compared with states where neither recreational nor medical legalization has occurred.
In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?
A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.
While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?
What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?
Researchers analyzed pooled safety data from 3 clinical trials of lebrikizumab for uncontrolled asthma to determine the drug’s safety profile.
A post hoc analysis of the PATHWAY and NAVIGATOR trials assessed efficacy of tezepelumab in Hispanic/Latino patients with severe, uncontrolled asthma.
Researchers evaluated asthma control in participants receiving maintenance and reliever digital system vs standard maintenance and reliever inhalers.
Which is a better predictor of morbidity in patients with severe asthma, blood eosinophil count or the number of patient-reported asthma triggers?
Researchers compared asthma exacerbation and cotricosteroid prescription reduction patients with asthma treated with dupilumab vs omalizumab, benralizumab, or mepolizumab.
Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity.
In addition to worsening asthma, other respiratory disorders, and heart conditions, exposure to wildfire smoke can also compromise immunity in healthy individuals.
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations.
A clinical trial of bronchial thermoplasty for severe asthma assessed efficacy and safety outcomes up to 5 years post-treatment.
Can combining dupilumab with house dust mite sublingual immunotherapy effectively control asthma in patients with HDM-related asthma and allergic rhinitis?
How effective are add-on devices for pressurized metered-dose inhalers in helping patients with asthma to avoid poor outcomes associated with incorrect inhaler use?
A new American Academy of Dermatology (AAD) guideline describes available evidence on comorbidities associated with atopic dermatitis in adults.
What is the difference in efficacy between mepolizumab and benralizumab, 2 biologics approved for the treatment of severe eosinophilic asthma?